DEVA Holding A.Ş. is one of Turkey's most established pharmaceutical manufacturers. Founded in 1958, it has expanded its production to encompass human pharmaceuticals, active substances, veterinary products, and medical ampoules. The company boasts a diverse product portfolio of over 650 items spanning 14 therapeutic areas such as oncology, cardiology, respiratory systems, and ophthalmology.
With its R&D center DEVARGE and production facilities approved by the European GMP and US FDA, DEVA maintains high-quality production standards. The company holds product licenses in more than 80 countries, including the USA, Germany, and Switzerland.
Operating out of Turkey, in Çerkezköy and Kartepe, DEVA's facilities have an annual production capacity of 620 million units. The company also invests in corporate social responsibility with initiatives aimed at public health, the environment, and education, driving towards a sustainable future.